Kovack Advisors »

Cyclerion Therapeutics shares owned by Kovack Advisors

Quarter-by-quarter ownership of Cyclerion Therapeutics (CYCN) shares owned by Kovack Advisors from 13F filings

Historical chart of Kovack Advisors investment in Cyclerion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclerion Therapeutics held by Kovack Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclerion Therapeutics by Kovack Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 10k 1.55

More positions owned by Kovack Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Strategy Series A Perp Pf (STRK)
Meta Platforms Cl A (META)

View all positions for Kovack Advisors

Top funds holding Cyclerion Therapeutics

Siren
Geode Capital Management
Vanguard Group
Citadel Advisors
BlackRock
Vanguard Capital Management
XTX Topco
Kovack Advisors
Vanguard Fiduciary Trust
FMR
UBS Group
Tower Research Capital
Group One Trading
Advisor Group Holdings
Activest Wealth Management

View all funds holding Cyclerion Therapeutics